ERBB2 and triple-negative breast carcinoma: To assess expression of DKK1 at tumor site, we analyzed a single-cell RNA seq dataset from 26 primary human breast tumors, including 11 ER+ (Luminal A or B), 5 HER2+, and 10 triple-negative breast cancers (TNBC) (GSE17607830).